Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Skin Neoplasms × Everolimus × Clear all

Sponsor

Conditions

Breast Neoplasms 34 Carcinoma, Renal Cell 29 Neoplasms 17 Kidney Neoplasms 15 Neuroendocrine Tumors 13 Neoplasm Metastasis 12 Tuberous Sclerosis 8 Prostatic Neoplasms 8 Carcinoma 8 Lymphoma, Mantle-Cell 7 Hodgkin Disease 7 Waldenstrom Macroglobulinemia 6 Recurrence 6 Lymphoma, Large B-Cell, Diffuse 6 Head and Neck Neoplasms 6 Glioma 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Lymphoma 5 Glioblastoma 5 Colorectal Neoplasms 5 Carcinoma, Neuroendocrine 5 Brain Neoplasms 5 Astrocytoma 5 Sezary Syndrome 4 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Mycosis Fungoides 4 Melanoma 4

Interventions

aldesleukin 14 Cyclophosphamide 14 fludarabine phosphate 11 fludarabine 11 Interleukin-2 9 Ipilimumab 6 Temozolomide 4 Nivolumab 4 trametinib 2 sonidegib 2 pembrolizumab 2 dabrafenib 2 binimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Sodium Chloride 2 Sirolimus 2 Radiotherapy 2 Radiation 2 Peptides 2 Gefitinib 2 Fluorouracil 2 Dacarbazine 2 Cyclosporine 2 Capecitabine 2 veliparib 1 varlilumab 1 tilsotolimod 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡